Stem Receives NYSE Notice After Falling Short of $50 Million Standard
Key Facts
Stem notified the New York Stock Exchange on October 19, 2026, that it did not meet a listing requirement stating that its average market capitalization must be at least $50 million over 30 consecutive trading days and that shareholders’ equity must be at least $50 million. The notice puts the company on two parallel tracks: addressing its status under exchange requirements and pursuing the strategic options review it announced about a year ago. Stem plans to submit a plan to the exchange within 45 days of receiving the noncompliance letter, explaining how it will regain compliance within 18 months. The company said its shares will remain listed and traded during the remediation period, subject to NYSE conditions. This comes as the company faces potential funding pressure: it said that a failure to improve cash flow or secure additional capital could constrain investment needed to execute its new strategy.
Stem’s board began reviewing strategic alternatives on November 20, 2025, according to a company filing. The options include a sale of the entire company or a merger. Stem said the review was intended to maximize shareholder value, but its announcement dates to that point, not to before third-quarter results, as earlier wording suggested. No new development on the review has been announced in the available filings. The company has set no deadline for the process and has not assured that it will result in a transaction. Stem said it will make no further announcements about the process unless its board determines that disclosure is appropriate or necessary, limiting the basis for viewing the upcoming earnings call as a confirmed time for an update to the market.
The strategic options review is linked to a financial position that the company said may require additional funding if operating cash flow does not improve as expected. Stem’s data showed cash and cash equivalents of $38.4 million on June 30, 2026, while operating expenses totaled $21.6 million in the quarter ended on the same date. The company warned that a failure to improve cash flow or secure additional funding sources could limit its ability to invest in executing its new strategy. The warning provides financial context for the review, but does not establish that funding pressure will lead to a sale or merger. Stem also said its current listing noncompliance does not affect its ongoing operations or its reporting obligations to the U.S. Securities and Exchange Commission.
The next step directly tied to the exchange notice is to submit a remediation plan within 45 days of receiving its letter; the plan must set out a path to regain compliance within 18 months of receiving the letter. During this period, the shares will remain listed and traded under exchange conditions, according to Stem’s filing. As for the results date, the investor relations calendar confirms that the third-quarter 2026 earnings call will take place on November 5 at 5:00 p.m. Eastern Time. The calendar does not confirm when the report itself will be released, and the company has not committed to updating investors on the strategic alternatives review during the call. In May, Chief Executive Officer Arun Narayanan said the company was making progress on its 2026 strategic priorities, which include improving operating leverage, strengthening its core business and building a foundation for growth. In August, Stem maintained its financial and operating guidance for the year and said the second quarter showed momentum in its PowerTrack platform and continued international expansion.